Division of Pediatric Hematology and Oncology Archive — Page 2 of 5
-
March 2, 2023
High-dose flu vaccine beneficial for pediatric stem cell transplant patients
Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. -
January 12, 2023
Expandable prosthesis gives young patient more mobility
To treat the osteosarcoma in his left leg, Dominic Gamez, 7, and his family chose to have a magnetic expandable prosthesis implanted that can be manipulated to grow incrementally as the child grows. -
June 24, 2022
Schwartz receives V Foundation for Cancer Research award
The V Foundation for Cancer Research has awarded a $200,000 grant to Jason Schwartz, MD, PhD, assistant professor in the Division of Pediatric Hematology and Oncology, to support his studies of childhood myelodysplastic syndromes (MDS), bone marrow disorders that can lead to cancer. -
March 24, 2022
Stress in young adult cancer patients and caregivers
Adolescent and young adult oncology patients and caregivers experience psychosocial impairment and financial toxicity at the time of cancer diagnosis, findings that will inform interventions to support patient and caregiver well-being. -
March 24, 2022
VUMC’s DeBaun elected president-elect of the American Pediatric Society
Vanderbilt's Michael DeBaun, MD, MS, MPH, has been elected president-elect of the American Pediatric Society. -
December 8, 2021
Treating children with cancer requires a strong blood supply; donations critically needed
-
May 27, 2021
Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track
A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.